Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Cue Biopharma Inc
(NQ:
CUE
)
12.61
USD
-0.12 (-0.94%)
Official Closing Price
Updated: 4:00 PM EST, Jan 15, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
248,900
Open
12.62
Bid (Size)
12.30 (1)
Ask (Size)
13.50 (1)
Prev. Close
12.73
Today's Range
12.50 - 13.10
52wk Range
9.300 - 31.69
Shares Outstanding
20,130,766
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Cue Biopharma to Present at the Piper Sandler 32nd Annual Healthcare Conference
November 23, 2020
From
GlobeNewswire News Releases
Cue Biopharma Extends Research Collaboration for the Development of Immuno-STAT Biologics for the Treatment of Defined Autoimmune Diseases with Merck
November 19, 2020
From
GlobeNewswire News Releases
Performance
YTD
+2.02%
+2.02%
1 Month
-4.25%
-4.25%
3 Month
-19.58%
-19.58%
6 Month
-43.17%
-43.17%
1 Year
-24.81%
-24.81%
More News
Read More
Cue Biopharma Reports Third Quarter 2020 Results and CUE-101 Phase 1 Dose Escalation Trial Updates
November 17, 2020
From
GlobeNewswire News Releases
Cue Biopharma to Present at Upcoming Investor Conferences in November 2020
November 11, 2020
From
GlobeNewswire News Releases
Cue Biopharma to Host Business Update Call and Webcast
November 10, 2020
From
GlobeNewswire News Releases
Cue Biopharma Announces Presentations Highlighting Clinical Progress of CUE-101, Pipeline Progress of CUE-100 Series Immuno-STATs and Immuno-STAT Data for Infectious Disease Applications at the Societ
November 09, 2020
From
GlobeNewswire News Releases
Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 35th Anniversary Annual Meeting
October 19, 2020
From
GlobeNewswire News Releases
Implied VHT Analyst Target Price: $244
January 05, 2021
Tags
ETFs
From
ETF Channel
Grab This Bargain Even Cheaper Than Director Fletcher Did
December 29, 2020
Tags
Stocks
From
Market News Video
The Math Shows LABU Can Go To $117
December 03, 2020
Tags
ETFs
From
ETF Channel
Noteworthy Tuesday Option Activity: CUE, FIVE, SSTK
December 01, 2020
Tags
Stocks
From
Market News Video
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.